sodium butyrate + probiotics

A combination oral preparation containing **microencapsulated sodium butyrate** (a short-chain fatty acid) and a multi-strain **probiotic blend** composed of *Lactobacillus rhamnosus*, *Lactobacillus acidophilus*, *Bifidobacterium longum*, *Bifidobacterium bifidum*, and *Bifidobacterium lactis*. It is sometimes formulated with a small amount of the prebiotic short-chain fructooligosaccharide (scFOS), but the queried product focuses on the sodium butyrate and probiotic constituents. **Sodium butyrate** acts as an energy source for colonocytes, promotes intestinal barrier integrity, exhibits anti-inflammatory properties (involving inhibition of nuclear factor kappa B), and modulates pain and motility in the gastrointestinal tract. **Probiotics** in this formulation contribute to restoring healthy gut flora and aid in the production of endogenous SCFAs including butyrate. The combination is designed to relieve gastrointestinal symptoms, particularly in patients with irritable bowel syndrome (IBS), by addressing gut dysbiosis, improving mucosal integrity, and reducing inflammation[1][3][5].